Zurich Cantonal Bank’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-932
Closed -$148K 2716
2023
Q4
$148K Buy
932
+118
+14% +$17K ﹤0.01% 2251
2023
Q3
$119K Hold
814
﹤0.01% 2276
2023
Q2
$123K Buy
814
+115
+16% +$17.9K ﹤0.01% 2237
2023
Q1
$107K Hold
699
﹤0.01% 2249
2022
Q4
$108K Buy
699
+123
+21% +$18.1K ﹤0.01% 2221
2022
Q3
$76K Hold
576
﹤0.01% 2408
2022
Q2
$79K Sell
576
-12
-2% -$1.65K ﹤0.01% 2388
2022
Q1
$88K Buy
588
+134
+30% +$19.8K ﹤0.01% 2338
2021
Q4
$74K Buy
+454
New +$73.4K ﹤0.01% 2618

Other funds holding FBT

Zurich Cantonal Bank's FBT Position: Q1 2024 in Review

Zurich Cantonal Bank sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2024, closing a stake of 932 shares — an estimated $148K sold.

Zurich Cantonal Bank first reported a position in FBT in Q4 2021 and held it in 9 quarters. The position peaked at $148K in Q4 2023. 243 funds tracked by Wall St. Rank hold FBT as of Q1 2024.

  • Zurich Cantonal Bank reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2024 after selling out during the quarter.
  • Zurich Cantonal Bank sold 932 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2024, an estimated $148K.
  • Zurich Cantonal Bank first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2021 and held it in 9 quarters.
  • Zurich Cantonal Bank's First Trust NYSE Arca Biotechnology Index Fund position peaked at $148K in Q4 2023.
  • 243 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2024.

Based on Zurich Cantonal Bank's 13F filing for Q1 2024, filed 25 Apr 2024.